Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.

Blood cancer discovery | 2022

Polycomb repressive epigenetic complexes are recurrently dysregulated in cancer. Unlike polycomb repressive complex 2 (PRC2), the role of PRC1 in oncogenesis and therapy resistance is not well-defined. Here, we demonstrate that highly recurrent mutations of the PRC1 subunits BCOR and BCORL1 in leukemia disrupt assembly of a noncanonical PRC1.1 complex, thereby selectively unlinking the RING-PCGF enzymatic core from the chromatin-targeting auxiliary subcomplex. As a result, BCOR-mutated PRC1.1 is localized to chromatin but lacks repressive activity, leading to epigenetic reprogramming and transcriptional activation at target loci. We define a set of functional targets that drive aberrant oncogenic signaling programs in PRC1.1-mutated cells and primary patient samples. Activation of these PRC1.1 targets in BCOR-mutated cells confers acquired resistance to treatment while sensitizing to targeted kinase inhibition. Our study thus reveals a novel epigenetic mechanism that explains PRC1.1 tumor-suppressive activity and identifies a therapeutic strategy in PRC1.1-mutated cancer.

Pubmed ID: 35015684 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


RING1 antibody (antibody)

RRID:AB_2238272

This polyclonal targets RING1

View all literature mentions

H3K27ac polyclonal antibody (antibody)

RRID:AB_2637079

This polyclonal targets H3K27ac

View all literature mentions

RNF2-human (antibody)

RRID:AB_10705604

This unknown targets RNF2

View all literature mentions

ChIPAb+ JHDM1B (antibody)

RRID:AB_11205420

This polyclonal targets ChIPAb+ JHDM1B

View all literature mentions

beta Actin antibody [mAbcam 8226] (HRP) - Loading Control (antibody)

RRID:AB_445482

This monoclonal targets beta Actin antibody [mAbcam 8226] (HRP) - Loading Control

View all literature mentions

FGF Receptor 1 (D8E4) XP Rabbit mAb (antibody)

RRID:AB_11178519

This monoclonal targets FGF Receptor 1 (D8E4) XP Rabbit mAb

View all literature mentions

HAUSP / USP7 antibody (antibody)

RRID:AB_2214019

This polyclonal targets USP7

View all literature mentions

MPc3 (C-3) (antibody)

RRID:AB_10990104

This monoclonal targets MPc3 (C-3)

View all literature mentions

Anti-DEDAF antibody produced in rabbit (antibody)

RRID:AB_1847589

This polyclonal targets DEDAF antibody produced in rabbit

View all literature mentions

H3K27me3-human (antibody)

RRID:AB_2616029

This unknown targets H3K27me3

View all literature mentions

Ubiquityl-Histone H2A (Lys119) (D27C4) XP Rabbit mAb (antibody)

RRID:AB_10891618

This monoclonal targets Histone H2A (Lys119)

View all literature mentions

RING1B (N-32) (antibody)

RRID:AB_1129072

This monoclonal targets Human RNF2

View all literature mentions

PCGF1 Antibody (E-8) (antibody)

RRID:AB_2721914

This monoclonal targets PCGF1

View all literature mentions

BCORL1 (antibody)

RRID:AB_2889363

This polyclonal targets BCORL1

View all literature mentions

BCoR Antibody (C-10) (antibody)

RRID:AB_2721913

This monoclonal targets BCoR

View all literature mentions

Anti-JHDM1B (antibody)

RRID:AB_10806072

This polyclonal targets JHDM1B

View all literature mentions

BCOR (antibody)

RRID:AB_2716801

This polyclonal targets BCOR

View all literature mentions

BCOR antibody (antibody)

RRID:AB_2290335

This polyclonal targets BCOR

View all literature mentions